Inotersen Subcutaneous and Onasemnogene abeparvovec Zolgensma
Determining the interaction of Inotersen Subcutaneous and Onasemnogene abeparvovec Zolgensma and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotersen
Brand name: Tegsedi
Synonyms: Inotersen
Generic Name: onasemnogene abeparvovec
Brand name: Zolgensma, Zolgensma
Synonyms: Onasemnogene abeparvovec (Zolgensma), Onasemnogene Abeparvovec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotersen Subcutaneous-Oncaspar
- Inotersen Subcutaneous-Oncovin
- Inotersen Subcutaneous-Ondansetron
- Inotersen Subcutaneous-Ondansetron and Dextrose
- Inotersen Subcutaneous-Ondansetron Hydrochloride
- Inotersen Subcutaneous-Ondansetron injection
- Onasemnogene abeparvovec Zolgensma-Inotuzumab ozogamicin
- Onasemnogene abeparvovec Zolgensma-Inotuzumab ozogamicin Intravenous
- Onasemnogene abeparvovec Zolgensma-Inova
- Onasemnogene abeparvovec Zolgensma-Inova 4/1 topical
- Onasemnogene abeparvovec Zolgensma-Inova 8/2 topical
- Onasemnogene abeparvovec Zolgensma-Inova ACT